US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Oncolytics Biotech Inc

0.5610

-0.0070-1.23%

Post-market: 0.5500-0.0110-1.96%19:38 EDT

Volume:214.46K

Turnover:118.44K

Market Cap:48.58M

PE:-1.95

High:0.5680

Open:0.5588

Low:0.5466

Close:0.5680

Loading ...

Overview Company News Filings

Oncolytics Biotech® Announces Receipt of Nasdaq Notification Letter Regarding Minimum Bid Price Deficiency

Press Release: Oncolytics Biotech(R) Announces Matt Coffey, Ph.D. Will Not Return to CEO Role Following Medical Leave of Absence

Oncolytics Biotech (ONCY) Upgraded to Buy: What Does It Mean for the Stock?

Oncolytics Biotech Price Target Maintained With a $5.00/Share by HC Wainwright & Co.

Oncolytics Biotech Says German Regulatory Approval Received for Full Patient Enrollment in Pancreatic Cancer Study

MT Newswires Live

BUZZ-Oncolytics Biotech jumps after pancreatic cancer therapy gets regulatory nod

Oncolytics: PEI approves continuation of enrollment in Cohort 5 of GOBLET study

Regulatory Approval Clears Path for Oncolytics Biotech® to Advance Promising Pancreatic Cancer Treatment, Following a Review of Safety Data

Will Oncolytics Biotech (TSE:ONC) Spend Its Cash Wisely?

Simply Wall St.

Oncolytics Biotech® Highlights 2024 Achievements and Prepares for an Influential 2025 with Promising Breast and GI Cancer Data

Oncolytics: DSMB recommended continued enrollment in Cohort 5 of GOBLET study

Oncolytics Biotech Price Target Maintained With a $5.00/Share by HC Wainwright & Co.

Oncolytics Biotech Inc (ONCY) Q3 2024 Earnings Call Highlights: Strategic Advances and ...

Oncolytics Biotech Inc reports results for the quarter ended September 30 - Earnings Summary

Oncolytics Biotech Reported Q3 $19.6M In Cash And Cash Equivalents, Projected To Provide Cash Runway Through Key Milestones And Into 2025

Oncolytics Biotech Q3 2024 GAAP EPS C$(0.12) Misses C$(0.10) Estimate

Oncolytics Biotech® Reports Third Quarter 2024 Financial Results and Operational Highlights

Press Release: Oncolytics Biotech(R) Reports Third Quarter 2024 Financial Results and Operational Highlights

Oncolytics Biotech® to Host Conference Call to Discuss Third Quarter Financial Results and Recent Operational Highlights

Oncolytics Biotech Inc expected to post a loss of 10 cents a share - Earnings Preview

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/ONCY/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ONCY","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ONCY\",,,,,undefined,":{"symbol":"ONCY","market":"US","secType":"STK","nameCN":"Oncolytics Biotech Inc","latestPrice":0.561,"timestamp":1744920000000,"preClose":0.568,"halted":0,"volume":214464,"hourTrading":{"tag":"盘后","latestPrice":0.55,"preClose":0.561,"latestTime":"19:38 EDT","volume":1501,"amount":825.561,"timestamp":1744933135748},"delay":0,"floatShares":83548724,"shares":86600868,"eps":-0.28815,"marketStatus":"Market Closed","change":-0.007,"latestTime":"04-17 16:00:00 EDT","open":0.5588,"high":0.568,"low":0.5466,"amount":118441.527636,"amplitude":0.037676,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.28815,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1745222400000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":1002254400000,"exchange":"NASDAQ","adjPreClose":0.568,"preHourTrading":{"tag":"盘前","latestPrice":0.568,"preClose":0.568,"latestTime":"08:22 EDT","volume":5694,"amount":2682.7070322,"timestamp":1744892554565},"postHourTrading":{"tag":"盘后","latestPrice":0.55,"preClose":0.561,"latestTime":"19:38 EDT","volume":1501,"amount":825.561,"timestamp":1744933135748},"volumeRatio":0.34823646872429037},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ONCY\",,,,,undefined,":{"symbol":"ONCY","floatShares":83548724,"roa":"-74.11%","roe":"-189.05%","lyrEps":-0.28815,"volumeRatio":0.34823646872429037,"shares":86600868,"dividePrice":0,"high":0.568,"amplitude":0.037676,"preClose":0.568,"low":0.5466,"week52Low":0.4679,"pbRate":"11.24","week52High":1.53,"institutionHeld":-0.0159,"latestPrice":0.561,"eps":-0.28815,"divideRate":0,"volume":214464,"delay":0,"ttmEps":-0.28815,"open":0.5588,"prevYearClose":0.9138,"prevWeekClose":0.6229,"prevMonthClose":0.55,"prevQuarterClose":0.55,"fiveDayClose":0.5001,"twentyDayClose":0.6264,"sixtyDayClose":0.88},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ONCY\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2511433126","title":"Oncolytics Biotech® Announces Receipt of Nasdaq Notification Letter Regarding Minimum Bid Price Deficiency","url":"https://stock-news.laohu8.com/highlight/detail?id=2511433126","media":"PR Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511433126?lang=en_us&edition=fundamental","pubTime":"2025-02-15 06:15","pubTimestamp":1739571300,"startTime":"0","endTime":"0","summary":"SAN DIEGO and CALGARY, AB, Feb. 14, 2025 /PRNewswire/ --Oncolytics BiotechInc.  , a leading clinical-stage company specializing in immunotherapy for oncology, today announced that it received a delinquency notification letter  from the Listing Qualifications Department of The Nasdaq Stock Market LLC  on February 13, 2025 indicating that the Company is not currently in compliance with the minimum bid price requirement set forth in Nasdaq's Listing Rules for continued listing on the Nasdaq Capital Market, as the closing bid price for the Company's ordinary shares listed on the Nasdaq Capital Market was below $1.00 per share for 30 consecutive business days. Nasdaq Listing Rule 5550 requires listed securities to maintain a minimum bid price of $1.00 per share, and Nasdaq Listing Rule 5810 provides that a failure to meet the minimum bid price requirement exists if the deficiency continues for a period of 30 consecutive business days. The Notice provides that the Company has a period of 180","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/oncolytics-biotech-announces-receipt-nasdaq-221500594.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/oncolytics-biotech-announces-receipt-nasdaq-221500594.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU1721428933.USD","NVIW.SI","TQQQ","BK4121","BK4139","LU0347712357.USD","LU1165135440.EUR","A","LU2041044095.USD","BK4588","QLD","NDAQ","QID","IE00BKPKM429.USD","BK4585","LU2413666426.HKD","SQQQ","LU1543694498.USD","ONCY","LU2413666699.HKD","IE00B64PRP62.GBP","IE00BN0W2V16.EUR","IE00BN0W2W23.USD","BK4567","USAW.SI","IE00BN0W2T93.GBP","USJW.SI","LU2210150020.SGD","PSQ","LU2092937221.SGD","TSYW.SI","IE00B3QW5Z07.USD","NQmain","IE00BGHQF748.EUR",".IXIC","LU2095319765.USD","MNQmain","BK4112","LU2210149790.SGD"],"gpt_icon":1},{"id":"2509707357","title":"Press Release: Oncolytics Biotech(R) Announces Matt Coffey, Ph.D. Will Not Return to CEO Role Following Medical Leave of Absence","url":"https://stock-news.laohu8.com/highlight/detail?id=2509707357","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509707357?lang=en_us&edition=fundamental","pubTime":"2025-02-08 10:24","pubTimestamp":1738981440,"startTime":"0","endTime":"0","summary":"Oncolytics Biotech Announces Matt Coffey, Ph.D. Will Not Return to CEO Role Following Medical Leave of Absence. Search for Chief Executive Officer to commence immediately. SAN DIEGO and CALGARY, AB, Feb. 7, 2025 /CNW/ -- Oncolytics Biotech Inc.  , a leading clinical-stage company specializing in immunotherapy for oncology, today announced that Matt Coffey, Ph.D., President and Chief Executive Officer, will not return following a medical leave of absence and ongoing health concerns. After much thought and consideration, Dr. Coffey reached a decision that in the best interest of his family and Oncolytics Biotech Inc., he would officially step down as CEO and Director of the company.Oncolytics is a clinical-stage biotechnology company developing pelareorep, an intravenously delivered immunotherapeutic agent. Pelareorep has demonstrated promising results in two randomized Phase 2 studies in metastatic breast cancer and Phase 1 and 2 studies in pancreatic cancer. It acts by inducing anti-ca","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4232","R","BK4022","ONCY"],"gpt_icon":0},{"id":"2509237202","title":"Oncolytics Biotech (ONCY) Upgraded to Buy: What Does It Mean for the Stock?","url":"https://stock-news.laohu8.com/highlight/detail?id=2509237202","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509237202?lang=en_us&edition=fundamental","pubTime":"2025-02-06 01:00","pubTimestamp":1738774813,"startTime":"0","endTime":"0","summary":"Oncolytics Biotech Inc.  could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 . This upgrade primarily reflects an upward trend in earnings estimates, which is one of the most powerful forces impacting stock prices.A company's changing earnings picture is at the core of the Zacks rating. The system tracks the Zacks Consensus Estimate -- the consensus measure of EPS estimates from the sell-side analysts covering the stock -- for the current and following years.Individual investors often find it hard to make decisions based on rating upgrades by Wall Street analysts, since these are mostly driven by subjective factors that are hard to see and measure in real time. In these situations, the Zacks rating system comes in handy because of the power of a changing earnings picture in determining near-term stock price movements.Therefore, the Zacks rating upgrade for Oncolytics Biotech basically reflects positivity about its earnings outlook that could translate into","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/oncolytics-biotech-oncy-upgraded-buy-170013932.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["ONCY"],"gpt_icon":0},{"id":"2508711485","title":"Oncolytics Biotech Price Target Maintained With a $5.00/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2508711485","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2508711485?lang=en_us&edition=fundamental","pubTime":"2025-02-03 19:41","pubTimestamp":1738582860,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/ONCY/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  February 03, 2025 06:41 ET (11:41 GMT)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ONCY"],"gpt_icon":0},{"id":"2503646891","title":"Oncolytics Biotech Says German Regulatory Approval Received for Full Patient Enrollment in Pancreatic Cancer Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2503646891","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503646891?lang=en_us&edition=fundamental","pubTime":"2025-01-15 21:26","pubTimestamp":1736947598,"startTime":"0","endTime":"0","summary":"Oncolytics Biotech  said Wednesday that Germany's Paul-Ehrlich-Institute has approved the continuation of patient enrollment in Cohort 5 of its GOBLET study.The company said the cohort will assess pelareorep combined with modified FOLFIRINOX with or without atezolizumab in patients newly diagnosed with pancreatic ductal adenocarcinoma.The approval, which paves the way for complete enrollment of 30 patients in Stage 1, follows a positive safety review by the Data Safety Monitoring Board that recommended the study's progression, Oncolytics Biotech said.The company also said it will present early safety data later in January, with preliminary efficacy results anticipated in H2.Oncolytics Biotech's shares were up nearly 7% in recent Wednesday premarket activity.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","ONCY"],"gpt_icon":0},{"id":"2503164314","title":"BUZZ-Oncolytics Biotech jumps after pancreatic cancer therapy gets regulatory nod","url":"https://stock-news.laohu8.com/highlight/detail?id=2503164314","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503164314?lang=en_us&edition=fundamental","pubTime":"2025-01-15 21:05","pubTimestamp":1736946357,"startTime":"0","endTime":"0","summary":"BUZZ-Oncolytics Biotech jumps after pancreatic cancer therapy gets regulatory nod** U.S.-listed shares of Oncolytics Biotech ONC.TO, ONCY.O rise 35.8% to $1.10 premarket** ONCY says its pancreatic cancer therapy, pelareorep, has received regulatory approval to continue patient enrollment** ONCY is evaluating pelareorep in combination with chemotherapy regimen Folfirinox and immunotherapy atezolizumab** ONCY says it will move forward with full enrollment of 30 newly diagnosed pancreatic ductal adenocarcinoma  patients in the first stage** All 5 brokerages covering the stock rate it \"buy\"** ONCY fell ~31% in 2024  ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250115:nL4N3OB101:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ONCY","BK4139"],"gpt_icon":0},{"id":"2503661796","title":"Oncolytics: PEI approves continuation of enrollment in Cohort 5 of GOBLET study","url":"https://stock-news.laohu8.com/highlight/detail?id=2503661796","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503661796?lang=en_us&edition=fundamental","pubTime":"2025-01-15 20:11","pubTimestamp":1736943062,"startTime":"0","endTime":"0","summary":"Oncolytics (ONCY) Biotech announced that Germany’s medical regulatory body, the Paul-Ehrlich-Institute, has approved the continuation of patient en...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/oncolytics-pei-approves-continuation-of-enrollment-in-cohort-5-of-goblet-study?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/oncolytics-pei-approves-continuation-of-enrollment-in-cohort-5-of-goblet-study?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ONCY","BK4139"],"gpt_icon":0},{"id":"2503617342","title":"Regulatory Approval Clears Path for Oncolytics Biotech® to Advance Promising Pancreatic Cancer Treatment, Following a Review of Safety Data","url":"https://stock-news.laohu8.com/highlight/detail?id=2503617342","media":"PR Newswire","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503617342?lang=en_us&edition=fundamental","pubTime":"2025-01-15 20:00","pubTimestamp":1736942400,"startTime":"0","endTime":"0","summary":"New pancreatic cancer cohort moves forward with full enrollment of 30 patients in Stage 1. SAN DIEGO and CALGARY, AB, Jan. 15, 2025 /PRNewswire/ -- Oncolytics BiotechInc.  , a leading clinical-stage company specializing in immunotherapy for oncology, today announced that Germany's medical regulatory body, the Paul-Ehrlich-Institute , has approved the continuation of patient enrollment into Cohort 5 of the GOBLET study. This cohort is evaluating pelareorep in combination with modified FOLFIRINOX  with or without atezolizumab  in newly diagnosed pancreatic ductal adenocarcinoma  patients.Following a positive safety review by the independent Data Safety Monitoring Board , which recommended continuation, the PEI's approval allows Cohort 5 to progress to full enrollment. Early safety data will be presented at the upcoming 2025 American Society of Clinical Oncology  Gastrointestinal Cancers Symposium later this month, with initial efficacy results expected in the second half of the year.Abou","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/regulatory-approval-clears-path-oncolytics-120000409.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/regulatory-approval-clears-path-oncolytics-120000409.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["AIO","BK4139","ONCY"],"gpt_icon":0},{"id":"2500981448","title":"Will Oncolytics Biotech (TSE:ONC) Spend Its Cash Wisely?","url":"https://stock-news.laohu8.com/highlight/detail?id=2500981448","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2500981448?lang=en_us&edition=fundamental","pubTime":"2025-01-01 20:07","pubTimestamp":1735733244,"startTime":"0","endTime":"0","summary":"Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the right price. For example, although software-as-a-service business Salesforce.com lost money for years while it grew recurring revenue, if you held shares since 2005, you'd have done very well indeed. Having said that, unprofitable companies are risky because they could potentially burn through all their cash and become distressed.So should Oncolytics Biotech  shareholders be worried about its cash burn?In this report, we will consider the company's annual negative free cash flow, henceforth referring to it as the 'cash burn'. We'll start by comparing its cash burn with its cash reserves in order to calculate its cash runway.Check out our latest analysis for Oncolytics Biotech. When Might Oncolytics Biotech Run Out Of Money?Oncolytics Biotech has a market capitalisation of CA$103m and burnt through CA$25m last year, which is 25% of the company's market value. That's not ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/oncolytics-biotech-tse-onc-spend-120724044.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","ONCY","TSE","BK4090"],"gpt_icon":0},{"id":"2493759636","title":"Oncolytics Biotech® Highlights 2024 Achievements and Prepares for an Influential 2025 with Promising Breast and GI Cancer Data","url":"https://stock-news.laohu8.com/highlight/detail?id=2493759636","media":"PR Newswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2493759636?lang=en_us&edition=fundamental","pubTime":"2024-12-23 20:00","pubTimestamp":1734955200,"startTime":"0","endTime":"0","summary":"Promising BRACELET-1 results in HR+/HER2- metastatic breast cancer lay the foundation for potential registration-enabling study and accelerated approval. Advancing gastrointestinal cancer pipeline underscores potential for additional registration-enabling studies. SAN DIEGO and CALGARY, AB, Dec. 23, 2024 /PRNewswire/ -- Oncolytics Biotech Inc.  , a leading clinical-stage company specializing in immunotherapy for oncology, is providing a recap of the major accomplishments from 2024 and a preview of the milestones that are expected over the next 12 months. Following the promising BRACELET-1 readout, Oncolytics expects additional data readouts across our clinical development program in 2025, forming what it believes is a clear pathway to future commercialization opportunities.In September, we reported final efficacy results from BRACELET-1, a randomized controlled study that showed marked clinical benefit in patients who received pelareorep-based combination therapy, reinforcing our confi","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/i5RMwN3trQMNIFldeYIXCg--~B/aD0xNzQ7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/caf9efe53f239ce497937f5fab3fe90d","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/i5RMwN3trQMNIFldeYIXCg--~B/aD0xNzQ7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/caf9efe53f239ce497937f5fab3fe90d"],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/oncolytics-biotech-highlights-2024-achievements-120000962.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/oncolytics-biotech-highlights-2024-achievements-120000962.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","MBC","ONCY","BK4086"],"gpt_icon":0},{"id":"2488919845","title":"Oncolytics: DSMB recommended continued enrollment in Cohort 5 of GOBLET study","url":"https://stock-news.laohu8.com/highlight/detail?id=2488919845","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2488919845?lang=en_us&edition=fundamental","pubTime":"2024-12-03 20:13","pubTimestamp":1733228000,"startTime":"0","endTime":"0","summary":"Oncolytics (ONCY) Biotech announced that the Data Safety Monitoring Board has recommended continued enrollment in Cohort 5 of the GOBLET study foll...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/oncolytics-dsmb-recommended-continued-enrollment-in-cohort-5-of-goblet-study?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/oncolytics-dsmb-recommended-continued-enrollment-in-cohort-5-of-goblet-study?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ONCY","BK4139"],"gpt_icon":0},{"id":"2483222458","title":"Oncolytics Biotech Price Target Maintained With a $5.00/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2483222458","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483222458?lang=en_us&edition=fundamental","pubTime":"2024-11-14 18:52","pubTimestamp":1731581520,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/ONCY/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  November 14, 2024 05:52 ET (10:52 GMT)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ONCY"],"gpt_icon":0},{"id":"2483237630","title":"Oncolytics Biotech Inc (ONCY) Q3 2024 Earnings Call Highlights: Strategic Advances and ...","url":"https://stock-news.laohu8.com/highlight/detail?id=2483237630","media":"GuruFocus.com","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483237630?lang=en_us&edition=fundamental","pubTime":"2024-11-13 15:08","pubTimestamp":1731481700,"startTime":"0","endTime":"0","summary":"Cash and Cash Equivalents: $19.6 million as of September 30, 2024.Net Cash Used in Operating Activities: $19.1 million for the nine months ended September 30, 2024, compared to $22.3 million for the same period in 2023.General and Administrative Expenses: $3.1 million for Q3 2024, down from $5.2 million in Q3 2023.Research and Development Expenses: $6.8 million for Q3 2024, up from $5.8 million in Q3 2023.Net Loss: $9.5 million for Q3 2024, compared to $9.9 million for Q3 2023.Basic and Diluted Loss Per Share: 12 in Q3 2024, compared to 14 in Q3 2023.GuruFocus has detected 2 Warning Signs with ONCY.For the complete transcript of the earnings call, please refer to the full earnings call transcript.Oncolytics Biotech Inc  reported promising final data from the Bracelet One breast cancer study, showing substantial improvements in progression-free survival and overall survival when combining their therapeutic agent with paclitaxel.","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/DOtY0OR6nRiB8AALujIEVg--~B/aD00MDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/us.finance.gurufocus/0d08ad631036ab92845f79cde1eb970c","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/DOtY0OR6nRiB8AALujIEVg--~B/aD00MDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/us.finance.gurufocus/0d08ad631036ab92845f79cde1eb970c"],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/oncolytics-biotech-inc-oncy-q3-070820936.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["ONCY"],"gpt_icon":0},{"id":"2482707583","title":"Oncolytics Biotech Inc reports results for the quarter ended September 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2482707583","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2482707583?lang=en_us&edition=fundamental","pubTime":"2024-11-12 21:39","pubTimestamp":1731418793,"startTime":"0","endTime":"0","summary":"Oncolytics Biotech Inc reports results for the quarter ended September 30 - Earnings SummaryOncolytics Biotech Inc ONC.TO reported a quarterly adjusted loss of 12 cents per share for the quarter ended","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241112:nL8N3MJ1IL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ONCY"],"gpt_icon":0},{"id":"2482708212","title":"Oncolytics Biotech Reported Q3 $19.6M In Cash And Cash Equivalents, Projected To Provide Cash Runway Through Key Milestones And Into 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2482708212","media":"Benzinga","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2482708212?lang=en_us&edition=fundamental","pubTime":"2024-11-12 20:04","pubTimestamp":1731413053,"startTime":"0","endTime":"0","summary":"Oncolytics Biotech Reported Q3 $19.6M In Cash And Cash Equivalents, Projected To Provide Cash Runway Through Key Milestones And Into 2025","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/general/biotech/24/11/41896641/oncolytics-biotech-reported-q3-19-6m-in-cash-and-cash-equivalents-projected-to-provide-cash-runwa","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ONCY","BK4139"],"gpt_icon":0},{"id":"2482135708","title":"Oncolytics Biotech Q3 2024 GAAP EPS C$(0.12) Misses C$(0.10) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2482135708","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2482135708?lang=en_us&edition=fundamental","pubTime":"2024-11-12 20:03","pubTimestamp":1731412986,"startTime":"0","endTime":"0","summary":"Oncolytics Biotech (NASDAQ:ONCY) reported quarterly losses of $(0.12) per share which missed the analyst consensus estimate of $(0.10) by 20 percent.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/24/11/41896579/oncolytics-biotech-q3-2024-gaap-eps-c-0-12-misses-c-0-10-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Oncolytics Biotech Q3 2024 GAAP EPS C$(0.12) Misses C$(0.10) Estimate","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ONCY"],"gpt_icon":0},{"id":"2482766708","title":"Oncolytics Biotech® Reports Third Quarter 2024 Financial Results and Operational Highlights","url":"https://stock-news.laohu8.com/highlight/detail?id=2482766708","media":"PR Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2482766708?lang=en_us&edition=fundamental","pubTime":"2024-11-12 20:00","pubTimestamp":1731412800,"startTime":"0","endTime":"0","summary":"BRACELET-1 data showing impressive overall survival benefit in HR+/HER2- metastatic breast cancer affirms pelareorep + paclitaxel combination should be evaluated in a registrational study. Upcoming GOBLET milestones include updated efficacy data from anal cancer cohort and safety run-in data from the modified FOLFIRINOX pancreatic cancer cohort. Cash position of$19.6 millionas of September 30, 2024. Management hosting conference call and webcast today at8:30 a.m. ET. SAN DIEGO and CALGARY, AB, Nov. 12, 2024 /PRNewswire/ -- Oncolytics BiotechInc.  , a leading clinical-stage company specializing in immunotherapy for oncology, today announced third quarter financial results and operational highlights.","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/i5RMwN3trQMNIFldeYIXCg--~B/aD0xNzQ7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/caf9efe53f239ce497937f5fab3fe90d","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/i5RMwN3trQMNIFldeYIXCg--~B/aD0xNzQ7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/caf9efe53f239ce497937f5fab3fe90d"],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/oncolytics-biotech-reports-third-quarter-120000610.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/oncolytics-biotech-reports-third-quarter-120000610.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","ONCY"],"gpt_icon":0},{"id":"2482703891","title":"Press Release: Oncolytics Biotech(R) Reports Third Quarter 2024 Financial Results and Operational Highlights","url":"https://stock-news.laohu8.com/highlight/detail?id=2482703891","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2482703891?lang=en_us&edition=fundamental","pubTime":"2024-11-12 20:00","pubTimestamp":1731412800,"startTime":"0","endTime":"0","summary":"BRACELET-1 data showing impressive overall survival benefit in HR+/HER2- metastatic breast cancer affirms pelareorep + paclitaxel combination should be evaluated in a registrational study. Upcoming GOBLET milestones include updated efficacy data from anal cancer cohort and safety run-in data from the modified FOLFIRINOX pancreatic cancer cohort. Cash position of $19.6 million as of September 30, 2024. BRACELET-1 data exceeds expectations, providing clear evidence of pelareorep's ability to improve outcomes in patients with advanced HR+/HER2- breast cancer , demonstrating progression-free survival of 12.1 months for pelareorep + paclitaxel compared to 6.4 months for paclitaxel alone, yielding a benefit of 5.7 months. Additionally, 64% of patients treated with pelareorep + paclitaxel lived at least two years compared to only 33% of patients treated with paclitaxel alone. Overall survival could not be calculated as more than half of the pelareorep + paclitaxel patients were alive at the e","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["R","BK4022","BK4139","BK4232","ONCY"],"gpt_icon":0},{"id":"2482883747","title":"Oncolytics Biotech® to Host Conference Call to Discuss Third Quarter Financial Results and Recent Operational Highlights","url":"https://stock-news.laohu8.com/highlight/detail?id=2482883747","media":"PR Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2482883747?lang=en_us&edition=fundamental","pubTime":"2024-11-11 20:00","pubTimestamp":1731326400,"startTime":"0","endTime":"0","summary":"Conference call and webcast to take place on Tuesday, November 12, 2024, at 8:30 a.m. ET. SAN DIEGO and CALGARY, AB, Nov. 11, 2024 /PRNewswire/ -- Oncolytics BiotechInc.  , a leading clinical-stage company specializing in immunotherapy for oncology, today announced that it will host a conference call and webcast on Tuesday, November 12, 2024, at 8:30 a.m. ET to discuss a corporate update and financial results for the third quarter 2024.A webcast of the call will also be available on the Investor Relations page of Oncolytics' website, available by clickinghere, and will be archived for three months. A dial-in replay will be available for one week and can be accessed by dialing  660-6345  or  819-1450  and using replay code: 68336#.Oncolytics is a clinical-stage biotechnology company developing pelareorep, an intravenously delivered immunotherapeutic agent. Pelareorep has demonstrated promising results in two randomized Phase 2 studies in metastatic breast cancer and Phase 1 and 2 studie","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/i5RMwN3trQMNIFldeYIXCg--~B/aD0xNzQ7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/caf9efe53f239ce497937f5fab3fe90d","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/i5RMwN3trQMNIFldeYIXCg--~B/aD0xNzQ7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/caf9efe53f239ce497937f5fab3fe90d"],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/oncolytics-biotech-host-conference-call-120000428.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/oncolytics-biotech-host-conference-call-120000428.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4181","BK4585","BK4588","BK4139","HST","BK4218","ONCY"],"gpt_icon":0},{"id":"2481883774","title":"Oncolytics Biotech Inc  expected to post a loss of 10 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2481883774","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481883774?lang=en_us&edition=fundamental","pubTime":"2024-11-08 23:30","pubTimestamp":1731079858,"startTime":"0","endTime":"0","summary":"Oncolytics Biotech Inc  expected to post a loss of10cents a share - Earnings Preview Oncolytics Biotech Inc ONC.TO  is expected to show no change in quarterly revenue when it reports  results on Novem","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241108:nL8N3MF1X1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ONCY"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":2,"totalSize":40,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ONCY\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-03-07","symbol":"ONCY","fiscalQuarterEnding":"2024/12","expectedEps":-0.08,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1741323600000,"reportTimeType":"pre","actualEps":-0.07},{"market":"US","date":"2024-11-12","symbol":"ONCY","fiscalQuarterEnding":"2024/09","expectedEps":-0.08,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1731387600000,"reportTimeType":"pre","actualEps":-0.09},{"market":"US","date":"2024-08-01","symbol":"ONCY","fiscalQuarterEnding":"2024/06","expectedEps":-0.08,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1722484800000,"reportTimeType":"post","actualEps":-0.07},{"market":"US","date":"2024-05-09","symbol":"ONCY","fiscalQuarterEnding":"2024/03","expectedEps":-0.09,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1715227200000,"reportTimeType":"post","actualEps":-0.07},{"market":"US","date":"2024-03-07","symbol":"ONCY","fiscalQuarterEnding":"2023/12","expectedEps":-0.11,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1709787600000,"reportTimeType":"post","actualEps":-0.04}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ONCY\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ONCY\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":4,"updateTime":1741665600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ONCY\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ONCY","date":"2025-04-17","current":-2.130201,"percent":0.992653,"low":-13.599624,"twenty":-5.723126,"median":-4.208011,"eighty":-3.542136,"high":-1.907761,"avg":-4.737783,"sd":1.77904,"marketCap":48724466.58},"quantilePoints":[{"date":"2020-04-24","current":-2.127592,"twenty":-6.835181,"median":-5.110946,"eighty":-2.611019,"marketCap":50001416.91},{"date":"2020-05-01","current":-2.373945,"twenty":-6.835181,"median":-5.10828,"eighty":-2.609722,"marketCap":55788284.25},{"date":"2020-05-08","current":-3.379629,"twenty":-6.823825,"median":-5.097543,"eighty":-2.592249,"marketCap":67408853.49},{"date":"2020-05-15","current":-4.086664,"twenty":-6.814784,"median":-5.060668,"eighty":-2.609722,"marketCap":80584953.37},{"date":"2020-05-22","current":-5.076513,"twenty":-6.807625,"median":-5.082963,"eighty":-2.611019,"marketCap":100534758.87},{"date":"2020-05-29","current":-4.722996,"twenty":-6.801128,"median":-5.06859,"eighty":-2.611019,"marketCap":95053387.42},{"date":"2020-06-05","current":-4.044242,"twenty":-6.799504,"median":-5.036302,"eighty":-2.61477,"marketCap":83817289.02},{"date":"2020-06-12","current":-3.993169,"twenty":-6.799504,"median":-5.01713,"eighty":-2.615708,"marketCap":81521945.54},{"date":"2020-06-19","current":-4.022316,"twenty":-6.798119,"median":-5.010163,"eighty":-2.615708,"marketCap":82260851.04},{"date":"2020-06-26","current":-3.803712,"twenty":-6.789892,"median":-5.004834,"eighty":-2.615708,"marketCap":77105692.23},{"date":"2020-07-02","current":-3.67255,"twenty":-6.767161,"median":-5.002174,"eighty":-2.618462,"marketCap":75031519.31},{"date":"2020-07-10","current":-3.774565,"twenty":-6.75332,"median":-4.920647,"eighty":-2.620733,"marketCap":77131608.17},{"date":"2020-07-17","current":-3.964022,"twenty":-6.747756,"median":-4.9067,"eighty":-2.621023,"marketCap":81130173.47},{"date":"2020-07-24","current":-3.993169,"twenty":-6.744046,"median":-4.848536,"eighty":-2.624871,"marketCap":82678013.76},{"date":"2020-07-31","current":-3.891154,"twenty":-6.744046,"median":-4.793059,"eighty":-2.634475,"marketCap":80722804.11},{"date":"2020-08-07","current":-3.63246,"twenty":-6.744046,"median":-4.759498,"eighty":-2.640099,"marketCap":79736445.27},{"date":"2020-08-14","current":-3.164214,"twenty":-6.721571,"median":-4.714666,"eighty":-2.640907,"marketCap":70088883.27},{"date":"2020-08-21","current":-3.121646,"twenty":-6.70473,"median":-4.675375,"eighty":-2.646951,"marketCap":69459902.23},{"date":"2020-08-28","current":-3.249349,"twenty":-6.696341,"median":-4.643802,"eighty":-2.650897,"marketCap":72786355.21},{"date":"2020-09-04","current":-3.022321,"twenty":-6.691575,"median":-4.62212,"eighty":-2.656982,"marketCap":67621388.56},{"date":"2020-09-11","current":-3.064888,"twenty":-6.670056,"median":-4.525026,"eighty":-2.661039,"marketCap":68261148.12},{"date":"2020-09-18","current":-3.561514,"twenty":-6.636276,"median":-4.493345,"eighty":-2.661039,"marketCap":79386423.1},{"date":"2020-09-25","current":-3.206781,"twenty":-6.613874,"median":-4.43823,"eighty":-2.661674,"marketCap":70202838.84},{"date":"2020-10-02","current":-3.263539,"twenty":-6.582251,"median":-4.427808,"eighty":-2.662626,"marketCap":72006474.57},{"date":"2020-10-09","current":-3.63246,"twenty":-6.576567,"median":-4.398633,"eighty":-2.662626,"marketCap":81202106.16},{"date":"2020-10-16","current":-3.63246,"twenty":-6.562418,"median":-4.360031,"eighty":-2.663581,"marketCap":80885533.55},{"date":"2020-10-23","current":-4.25679,"twenty":-6.542273,"median":-4.293505,"eighty":-2.667425,"marketCap":95067509.03},{"date":"2020-10-30","current":-3.944625,"twenty":-6.529621,"median":-4.256571,"eighty":-2.671043,"marketCap":87029334.32},{"date":"2020-11-06","current":-4.015571,"twenty":-6.525043,"median":-4.254724,"eighty":-2.672325,"marketCap":90475985.23},{"date":"2020-11-13","current":-3.548652,"twenty":-6.518641,"median":-4.226997,"eighty":-2.674291,"marketCap":87838741.32},{"date":"2020-11-20","current":-3.880923,"twenty":-6.506044,"median":-4.18627,"eighty":-2.674356,"marketCap":96771404.73},{"date":"2020-11-27","current":-4.771409,"twenty":-6.497006,"median":-4.225582,"eighty":-2.674742,"marketCap":119748456.18},{"date":"2020-12-04","current":-6.808049,"twenty":-6.497006,"median":-4.249994,"eighty":-2.677239,"marketCap":173214731.54},{"date":"2020-12-11","current":-4.21514,"twenty":-6.509057,"median":-4.256352,"eighty":-2.681046,"marketCap":107587090.73},{"date":"2020-12-18","current":-3.975794,"twenty":-6.497006,"median":-4.249994,"eighty":-2.682054,"marketCap":101335928.99},{"date":"2020-12-24","current":-4.348109,"twenty":-6.497006,"median":-4.249994,"eighty":-2.686086,"marketCap":110447962.23},{"date":"2020-12-31","current":-4.015685,"twenty":-6.495476,"median":-4.236838,"eighty":-2.68692,"marketCap":102670773.03},{"date":"2021-01-08","current":-4.348109,"twenty":-6.495093,"median":-4.228411,"eighty":-2.687838,"marketCap":111425354.76},{"date":"2021-01-15","current":-4.65394,"twenty":-6.493879,"median":-4.255538,"eighty":-2.690443,"marketCap":119050036.51},{"date":"2021-01-22","current":-4.321515,"twenty":-6.483152,"median":-4.256571,"eighty":-2.695109,"marketCap":110632462.91},{"date":"2021-01-29","current":-4.21514,"twenty":-6.475912,"median":-4.256352,"eighty":-2.697815,"marketCap":107431377.23},{"date":"2021-02-05","current":-4.627346,"twenty":-6.475718,"median":-4.256352,"eighty":-2.697815,"marketCap":117992670.75},{"date":"2021-02-12","current":-4.534267,"twenty":-6.454876,"median":-4.28689,"eighty":-2.697815,"marketCap":116290993.83},{"date":"2021-02-19","current":-5.7044,"twenty":-6.440583,"median":-4.294922,"eighty":-2.699111,"marketCap":147474178.27},{"date":"2021-02-26","current":-5.438461,"twenty":-6.440583,"median":-4.321515,"eighty":-2.701054,"marketCap":139504050.3},{"date":"2021-03-05","current":-7.868711,"twenty":-6.440583,"median":-4.334812,"eighty":-2.70433,"marketCap":139536160.27},{"date":"2021-03-12","current":-8.609296,"twenty":-6.476008,"median":-4.348109,"eighty":-2.709365,"marketCap":155168097.8},{"date":"2021-03-19","current":-8.956445,"twenty":-6.496241,"median":-4.348109,"eighty":-2.714152,"marketCap":161134522.07},{"date":"2021-03-26","current":-10.761619,"twenty":-6.525043,"median":-4.388037,"eighty":-2.721062,"marketCap":192601211.96},{"date":"2021-04-01","current":-11.108768,"twenty":-6.545773,"median":-4.407132,"eighty":-2.721062,"marketCap":198915394.29},{"date":"2021-04-09","current":-11.700366,"twenty":-6.582949,"median":-4.429576,"eighty":-2.721062,"marketCap":209675470.41},{"date":"2021-04-16","current":-8.722518,"twenty":-6.691575,"median":-4.438684,"eighty":-2.721105,"marketCap":157033925.84},{"date":"2021-04-23","current":-8.769413,"twenty":-6.744046,"median":-4.459584,"eighty":-2.721275,"marketCap":157945160.54},{"date":"2021-04-30","current":-8.769413,"twenty":-6.75332,"median":-4.500218,"eighty":-2.723225,"marketCap":160201666.5},{"date":"2021-05-07","current":-6.428347,"twenty":-6.799158,"median":-4.525026,"eighty":-2.731032,"marketCap":155314212.66},{"date":"2021-05-14","current":-6.037057,"twenty":-6.795803,"median":-4.567509,"eighty":-2.731066,"marketCap":146341142.64},{"date":"2021-05-21","current":-6.707841,"twenty":-6.795803,"median":-4.62212,"eighty":-2.731066,"marketCap":163312350.22},{"date":"2021-05-28","current":-6.875537,"twenty":-6.799504,"median":-4.629271,"eighty":-2.731454,"marketCap":166868967.97},{"date":"2021-06-04","current":-6.931435,"twenty":-6.808049,"median":-4.642568,"eighty":-2.733004,"marketCap":168135221.95},{"date":"2021-06-11","current":-6.689208,"twenty":-6.808049,"median":-4.656409,"eighty":-2.733004,"marketCap":161409464.59},{"date":"2021-06-18","current":-6.801005,"twenty":-6.807625,"median":-4.704863,"eighty":-2.733004,"marketCap":159951456.12},{"date":"2021-06-25","current":-6.596043,"twenty":-6.807625,"median":-4.751277,"eighty":-2.74242,"marketCap":157439288.15},{"date":"2021-07-02","current":-6.353816,"twenty":-6.801005,"median":-4.759907,"eighty":-2.744734,"marketCap":150942936.15},{"date":"2021-07-09","current":-6.018424,"twenty":-6.799804,"median":-4.760316,"eighty":-2.749806,"marketCap":141562537.23},{"date":"2021-07-16","current":-5.6085,"twenty":-6.799504,"median":-4.771409,"eighty":-2.751074,"marketCap":130705502.25},{"date":"2021-07-23","current":-5.794829,"twenty":-6.799504,"median":-4.800206,"eighty":-2.751074,"marketCap":135136971.33},{"date":"2021-07-30","current":-5.384905,"twenty":-6.798119,"median":-4.824163,"eighty":-2.751074,"marketCap":126691179.98},{"date":"2021-08-06","current":-5.152783,"twenty":-6.789892,"median":-4.853084,"eighty":-2.752997,"marketCap":122002390.12},{"date":"2021-08-13","current":-4.857283,"twenty":-6.768576,"median":-4.906582,"eighty":-2.753478,"marketCap":115607403.82},{"date":"2021-08-20","current":-4.894221,"twenty":-6.763739,"median":-4.875927,"eighty":-2.754433,"marketCap":113306568.43},{"date":"2021-08-27","current":-5.300534,"twenty":-6.755404,"median":-4.9067,"eighty":-2.762563,"marketCap":124856930.94},{"date":"2021-09-03","current":-5.226659,"twenty":-6.75332,"median":-4.909695,"eighty":-2.764536,"marketCap":124279561.33},{"date":"2021-09-10","current":-5.005033,"twenty":-6.747756,"median":-4.920263,"eighty":-2.764536,"marketCap":117846825.97},{"date":"2021-09-17","current":-4.949627,"twenty":-6.744046,"median":-4.919879,"eighty":-2.764536,"marketCap":115533948.29},{"date":"2021-09-24","current":-5.06044,"twenty":-6.744046,"median":-4.925902,"eighty":-2.765336,"marketCap":118623914.7},{"date":"2021-10-01","current":-4.61719,"twenty":-6.744046,"median":-4.920647,"eighty":-2.767264,"marketCap":108402575.17},{"date":"2021-10-08","current":-4.487908,"twenty":-6.722323,"median":-4.909695,"eighty":-2.768193,"marketCap":107096920.66},{"date":"2021-10-15","current":-5.078908,"twenty":-6.707841,"median":-4.91269,"eighty":-2.768193,"marketCap":122176044.82},{"date":"2021-10-22","current":-5.152783,"twenty":-6.707841,"median":-4.920263,"eighty":-2.769926,"marketCap":124002267.56},{"date":"2021-10-29","current":-4.709533,"twenty":-6.707841,"median":-4.91269,"eighty":-2.773789,"marketCap":113036491},{"date":"2021-11-05","current":-5.170814,"twenty":-6.707089,"median":-4.916284,"eighty":-2.778889,"marketCap":115846574.53},{"date":"2021-11-12","current":-4.914247,"twenty":-6.70473,"median":-4.920647,"eighty":-2.784425,"marketCap":109057399.83},{"date":"2021-11-19","current":-4.322169,"twenty":-6.696341,"median":-4.913468,"eighty":-2.793287,"marketCap":95384237.1},{"date":"2021-11-26","current":-4.401113,"twenty":-6.691575,"median":-4.909695,"eighty":-2.802134,"marketCap":95957525.81},{"date":"2021-12-03","current":-4.006394,"twenty":-6.690628,"median":-4.9067,"eighty":-2.808769,"marketCap":87249809.81},{"date":"2021-12-10","current":-4.105074,"twenty":-6.668636,"median":-4.894221,"eighty":-2.811306,"marketCap":90017550.28},{"date":"2021-12-17","current":-3.828771,"twenty":-6.636276,"median":-4.857633,"eighty":-2.815112,"marketCap":83306762.7},{"date":"2021-12-23","current":-3.749827,"twenty":-6.633882,"median":-4.857283,"eighty":-2.815498,"marketCap":81599285.87},{"date":"2021-12-31","current":-3.453788,"twenty":-6.625856,"median":-4.852909,"eighty":-2.817597,"marketCap":76095002.73},{"date":"2022-01-07","current":-3.256429,"twenty":-6.596043,"median":-4.838815,"eighty":-2.819827,"marketCap":71701389.1},{"date":"2022-01-14","current":-3.986658,"twenty":-6.593564,"median":-4.816924,"eighty":-2.819827,"marketCap":88594259.75},{"date":"2022-01-21","current":-4.65768,"twenty":-6.583647,"median":-4.813503,"eighty":-2.819827,"marketCap":103657357},{"date":"2022-01-28","current":-4.420849,"twenty":-6.580157,"median":-4.786909,"eighty":-2.830885,"marketCap":96597066.68},{"date":"2022-02-04","current":-4.578736,"twenty":-6.571181,"median":-4.785158,"eighty":-2.830885,"marketCap":99999941.25},{"date":"2022-02-11","current":-4.815567,"twenty":-6.569199,"median":-4.813503,"eighty":-2.831105,"marketCap":105863942.79},{"date":"2022-02-18","current":-4.381377,"twenty":-6.569199,"median":-4.813503,"eighty":-2.837056,"marketCap":95843503.74},{"date":"2022-02-25","current":-4.193885,"twenty":-6.569199,"median":-4.813503,"eighty":-2.837056,"marketCap":91777375.22},{"date":"2022-03-04","current":-4.168781,"twenty":-6.569199,"median":-4.813503,"eighty":-2.837056,"marketCap":85890549.78},{"date":"2022-03-11","current":-4.320767,"twenty":-6.569199,"median":-4.804667,"eighty":-2.837056,"marketCap":89380424.99},{"date":"2022-03-18","current":-4.407617,"twenty":-6.569199,"median":-4.772511,"eighty":-2.837056,"marketCap":91828409.17},{"date":"2022-03-25","current":-4.364192,"twenty":-6.569199,"median":-4.760316,"eighty":-2.837056,"marketCap":91844651.93},{"date":"2022-04-01","current":-4.331624,"twenty":-6.569199,"median":-4.741547,"eighty":-2.837056,"marketCap":91108219.32},{"date":"2022-04-08","current":-4.299055,"twenty":-6.569199,"median":-4.713211,"eighty":-2.837056,"marketCap":89823457.83},{"date":"2022-04-14","current":-4.125356,"twenty":-6.529405,"median":-4.694109,"eighty":-2.837056,"marketCap":86011128.55},{"date":"2022-04-22","current":-3.756245,"twenty":-6.521512,"median":-4.656409,"eighty":-2.837056,"marketCap":77792512.4},{"date":"2022-04-29","current":-3.71282,"twenty":-6.495093,"median":-4.631196,"eighty":-2.837056,"marketCap":76202013.08},{"date":"2022-05-06","current":-3.784901,"twenty":-6.44739,"median":-4.617699,"eighty":-2.837056,"marketCap":78389815.41},{"date":"2022-05-13","current":-3.179317,"twenty":-6.407895,"median":-4.561322,"eighty":-2.837056,"marketCap":65514943.78},{"date":"2022-05-20","current":-2.919781,"twenty":-6.379502,"median":-4.522187,"eighty":-2.837056,"marketCap":60604029.29},{"date":"2022-05-27","current":-3.136061,"twenty":-6.379502,"median":-4.499792,"eighty":-2.837056,"marketCap":65567152.84},{"date":"2022-06-03","current":-3.049549,"twenty":-6.379502,"median":-4.487908,"eighty":-2.837056,"marketCap":64584862.43},{"date":"2022-06-10","current":-2.884297,"twenty":-6.379502,"median":-4.471096,"eighty":-2.832836,"marketCap":60056500.57},{"date":"2022-06-17","current":-2.797551,"twenty":-6.379502,"median":-4.446115,"eighty":-2.819827,"marketCap":57106648.33},{"date":"2022-06-24","current":-2.819238,"twenty":-6.379502,"median":-4.441188,"eighty":-2.819591,"marketCap":58161496.48},{"date":"2022-07-01","current":-2.732492,"twenty":-6.379502,"median":-4.426041,"eighty":-2.818359,"marketCap":56380641.89},{"date":"2022-07-08","current":-2.840924,"twenty":-6.379502,"median":-4.398633,"eighty":-2.815112,"marketCap":58513310.3},{"date":"2022-07-15","current":-2.754178,"twenty":-6.379502,"median":-4.385905,"eighty":-2.808769,"marketCap":56387572.12},{"date":"2022-07-22","current":-2.949356,"twenty":-6.379502,"median":-4.364192,"eighty":-2.797551,"marketCap":61123167.73},{"date":"2022-07-29","current":-3.144535,"twenty":-6.379502,"median":-4.348109,"eighty":-2.797551,"marketCap":65380622.79},{"date":"2022-08-05","current":-3.426458,"twenty":-6.379502,"median":-4.334812,"eighty":-2.797551,"marketCap":70532964.35},{"date":"2022-08-12","current":-4.056883,"twenty":-6.379502,"median":-4.321515,"eighty":-2.797551,"marketCap":77670033.29},{"date":"2022-08-19","current":-3.651195,"twenty":-6.379502,"median":-4.299055,"eighty":-2.797551,"marketCap":68800200.76},{"date":"2022-08-26","current":-4.581891,"twenty":-6.379502,"median":-4.299055,"eighty":-2.797551,"marketCap":86353448.63},{"date":"2022-09-02","current":-4.176203,"twenty":-6.379502,"median":-4.295523,"eighty":-2.797551,"marketCap":78107249.31},{"date":"2022-09-09","current":-4.438707,"twenty":-6.379502,"median":-4.294922,"eighty":-2.797551,"marketCap":83344554.39},{"date":"2022-09-16","current":-4.104611,"twenty":-6.379502,"median":-4.277343,"eighty":-2.797551,"marketCap":75742392.58},{"date":"2022-09-23","current":-3.985291,"twenty":-6.363994,"median":-4.256352,"eighty":-2.797551,"marketCap":71967350.76},{"date":"2022-09-30","current":-4.152339,"twenty":-6.346477,"median":-4.243225,"eighty":-2.797551,"marketCap":74087710.4},{"date":"2022-10-07","current":-4.104611,"twenty":-6.284935,"median":-4.225582,"eighty":-2.797551,"marketCap":73472661.18},{"date":"2022-10-14","current":-4.056883,"twenty":-6.239764,"median":-4.223489,"eighty":-2.797551,"marketCap":71647689.73},{"date":"2022-10-21","current":-4.128475,"twenty":-6.205607,"median":-4.203753,"eighty":-2.797551,"marketCap":73704328.94},{"date":"2022-10-28","current":-4.080747,"twenty":-6.20024,"median":-4.200067,"eighty":-2.797551,"marketCap":73376310.96},{"date":"2022-11-04","current":-4.056883,"twenty":-6.196725,"median":-4.200067,"eighty":-2.797551,"marketCap":73532290.31},{"date":"2022-11-11","current":-5.354684,"twenty":-6.193595,"median":-4.200067,"eighty":-2.797551,"marketCap":96806195.08},{"date":"2022-11-18","current":-4.617801,"twenty":-6.176703,"median":-4.200067,"eighty":-2.797551,"marketCap":82978609.67},{"date":"2022-11-25","current":-5.207308,"twenty":-6.129818,"median":-4.200067,"eighty":-2.797551,"marketCap":93562528.88},{"date":"2022-12-02","current":-6.140693,"twenty":-6.106359,"median":-4.200067,"eighty":-2.797551,"marketCap":109573738.84},{"date":"2022-12-09","current":-5.698563,"twenty":-6.059802,"median":-4.200067,"eighty":-2.797551,"marketCap":100517873.47},{"date":"2022-12-16","current":-6.509135,"twenty":-6.018424,"median":-4.200067,"eighty":-2.797551,"marketCap":114237948.59},{"date":"2022-12-23","current":-5.723126,"twenty":-6.018028,"median":-4.200067,"eighty":-2.797551,"marketCap":101231262.88},{"date":"2022-12-30","current":-5.452936,"twenty":-6.01496,"median":-4.200067,"eighty":-2.797551,"marketCap":96824110.03},{"date":"2023-01-06","current":-5.330122,"twenty":-5.980988,"median":-4.200067,"eighty":-2.797551,"marketCap":95104355.32},{"date":"2023-01-13","current":-5.330122,"twenty":-5.963064,"median":-4.200067,"eighty":-2.797551,"marketCap":95508553.79},{"date":"2023-01-20","current":-6.214381,"twenty":-5.963064,"median":-4.200067,"eighty":-2.797551,"marketCap":111383189.14},{"date":"2023-01-27","current":-6.091568,"twenty":-5.951345,"median":-4.200067,"eighty":-2.797551,"marketCap":109962702.06},{"date":"2023-02-03","current":-6.091568,"twenty":-5.943892,"median":-4.200067,"eighty":-2.797551,"marketCap":109393253.67},{"date":"2023-02-10","current":-5.158182,"twenty":-5.941175,"median":-4.200067,"eighty":-2.797551,"marketCap":92779058.14},{"date":"2023-02-17","current":-5.477498,"twenty":-5.941175,"median":-4.200067,"eighty":-2.797551,"marketCap":97494370.34},{"date":"2023-02-24","current":-5.280996,"twenty":-5.941175,"median":-4.200067,"eighty":-2.797551,"marketCap":93194065.94},{"date":"2023-03-03","current":-5.514909,"twenty":-5.923824,"median":-4.200067,"eighty":-2.797551,"marketCap":100557820.31},{"date":"2023-03-10","current":-4.37651,"twenty":-5.896945,"median":-4.200067,"eighty":-2.797551,"marketCap":78895109.82},{"date":"2023-03-17","current":-4.578892,"twenty":-5.876043,"median":-4.200067,"eighty":-2.797551,"marketCap":82819370.46},{"date":"2023-03-24","current":-4.224724,"twenty":-5.845133,"median":-4.193885,"eighty":-2.797551,"marketCap":76297872.23},{"date":"2023-03-31","current":-4.174128,"twenty":-5.82631,"median":-4.184931,"eighty":-2.797551,"marketCap":76617674.67},{"date":"2023-04-06","current":-3.845258,"twenty":-5.79528,"median":-4.176203,"eighty":-2.797551,"marketCap":70824539.44},{"date":"2023-04-14","current":-4.040991,"twenty":-5.772252,"median":-4.168781,"eighty":-2.797551,"marketCap":75135145.62},{"date":"2023-04-21","current":-4.066406,"twenty":-5.746194,"median":-4.152339,"eighty":-2.797551,"marketCap":75010172.76},{"date":"2023-04-28","current":-4.473047,"twenty":-5.723126,"median":-4.152339,"eighty":-2.797551,"marketCap":81684240.09},{"date":"2023-05-05","current":-5.032178,"twenty":-5.71189,"median":-4.152339,"eighty":-2.797551,"marketCap":92015882.28},{"date":"2023-05-10","current":-5.721642,"twenty":-5.697071,"median":-4.148831,"eighty":-2.797551,"marketCap":104840412.96},{"date":"2023-05-19","current":-5.678422,"twenty":-5.678422,"median":-4.148655,"eighty":-2.795371,"marketCap":103012725.35},{"date":"2023-05-26","current":-7.654095,"twenty":-5.67674,"median":-4.148655,"eighty":-2.793191,"marketCap":137505129.9},{"date":"2023-06-02","current":-5.861597,"twenty":-5.67674,"median":-4.148655,"eighty":-2.793191,"marketCap":106607339.42},{"date":"2023-06-07","current":-5.521415,"twenty":-5.675618,"median":-4.148655,"eighty":-2.793191,"marketCap":101282945.26},{"date":"2023-06-16","current":-6.698968,"twenty":-5.661498,"median":-4.143275,"eighty":-2.786652,"marketCap":123983915.43},{"date":"2023-06-23","current":-8.679704,"twenty":-5.65877,"median":-4.139316,"eighty":-2.785539,"marketCap":161429989.45},{"date":"2023-06-30","current":-9.1282,"twenty":-5.650695,"median":-4.135358,"eighty":-2.784425,"marketCap":168785758.93},{"date":"2023-07-07","current":-10.922181,"twenty":-5.650695,"median":-4.135358,"eighty":-2.784425,"marketCap":200157855.79},{"date":"2023-07-14","current":-11.051786,"twenty":-5.650695,"median":-4.135358,"eighty":-2.784425,"marketCap":206272500.95},{"date":"2023-07-21","current":-10.139746,"twenty":-5.650695,"median":-4.135358,"eighty":-2.784425,"marketCap":188385818.31},{"date":"2023-07-28","current":-9.71055,"twenty":-5.650695,"median":-4.135358,"eighty":-2.784425,"marketCap":180247745.39},{"date":"2023-08-04","current":-8.074242,"twenty":-5.650695,"median":-4.135358,"eighty":-2.784425,"marketCap":148225459.45},{"date":"2023-08-11","current":-8.509457,"twenty":-5.66317,"median":-4.135358,"eighty":-2.784425,"marketCap":155529621.37},{"date":"2023-08-18","current":-7.280021,"twenty":-5.669007,"median":-4.135358,"eighty":-2.784425,"marketCap":144490354.28},{"date":"2023-08-25","current":-8.439431,"twenty":-5.675769,"median":-4.135358,"eighty":-2.784425,"marketCap":166984396.61},{"date":"2023-09-01","current":-8.385505,"twenty":-5.694087,"median":-4.135358,"eighty":-2.784425,"marketCap":166260588.02},{"date":"2023-09-08","current":-8.385505,"twenty":-5.711411,"median":-4.135358,"eighty":-2.784425,"marketCap":164565936.94},{"date":"2023-09-15","current":-8.091348,"twenty":-5.723126,"median":-4.135358,"eighty":-2.784425,"marketCap":160732260.91},{"date":"2023-09-22","current":-8.064013,"twenty":-5.757181,"median":-4.135358,"eighty":-2.784425,"marketCap":160485002.04},{"date":"2023-09-29","current":-8.118684,"twenty":-5.795623,"median":-4.135358,"eighty":-2.784425,"marketCap":161490413.83},{"date":"2023-10-06","current":-7.763321,"twenty":-5.84594,"median":-4.135358,"eighty":-2.784425,"marketCap":151677907.19},{"date":"2023-10-13","current":-6.88858,"twenty":-5.877207,"median":-4.135358,"eighty":-2.784425,"marketCap":135301495.79},{"date":"2023-10-20","current":-6.070993,"twenty":-5.904063,"median":-4.135358,"eighty":-2.784425,"marketCap":118770957.7},{"date":"2023-10-27","current":-5.906912,"twenty":-5.910509,"median":-4.148655,"eighty":-2.781085,"marketCap":114646719.5},{"date":"2023-11-03","current":-6.645276,"twenty":-5.934258,"median":-4.152339,"eighty":-2.781085,"marketCap":129327328.1},{"date":"2023-11-10","current":-4.128501,"twenty":-5.934258,"median":-4.166167,"eighty":-2.781085,"marketCap":97058794.34},{"date":"2023-11-17","current":-4.423394,"twenty":-5.934258,"median":-4.174128,"eighty":-2.781085,"marketCap":104033138.05},{"date":"2023-11-24","current":-5.035864,"twenty":-5.934258,"median":-4.179415,"eighty":-2.781085,"marketCap":118948696.24},{"date":"2023-12-01","current":-4.423394,"twenty":-5.934258,"median":-4.191216,"eighty":-2.781085,"marketCap":105451897.18},{"date":"2023-12-08","current":-4.332657,"twenty":-5.932949,"median":-4.200067,"eighty":-2.782198,"marketCap":103117839.99},{"date":"2023-12-15","current":-4.173869,"twenty":-5.932949,"median":-4.201843,"eighty":-2.799923,"marketCap":100704559.72},{"date":"2023-12-22","current":-3.833608,"twenty":-5.932949,"median":-4.203753,"eighty":-2.81748,"marketCap":93278126.53},{"date":"2023-12-29","current":-4.083133,"twenty":-5.934258,"median":-4.203753,"eighty":-2.819238,"marketCap":100106779.21},{"date":"2024-01-05","current":-4.008975,"twenty":-5.935279,"median":-4.203753,"eighty":-2.819709,"marketCap":97136778.69},{"date":"2024-01-12","current":-3.749144,"twenty":-5.935279,"median":-4.203753,"eighty":-2.819827,"marketCap":90263887.32},{"date":"2024-01-19","current":-3.63414,"twenty":-5.9363,"median":-4.203753,"eighty":-2.830885,"marketCap":87095855.18},{"date":"2024-01-26","current":-3.91015,"twenty":-5.935279,"median":-4.203753,"eighty":-2.837489,"marketCap":93719060.74},{"date":"2024-02-02","current":-3.657141,"twenty":-5.935279,"median":-4.203753,"eighty":-2.840924,"marketCap":88272795.49},{"date":"2024-02-09","current":-3.151121,"twenty":-5.935279,"median":-4.203753,"eighty":-2.840924,"marketCap":75691376.03},{"date":"2024-02-16","current":-3.588138,"twenty":-5.935279,"median":-4.203753,"eighty":-2.850789,"marketCap":85946905.28},{"date":"2024-02-23","current":-3.220124,"twenty":-5.935279,"median":-4.203753,"eighty":-2.864059,"marketCap":77184976.89},{"date":"2024-03-01","current":-3.49524,"twenty":-5.934258,"median":-4.203753,"eighty":-2.875118,"marketCap":83328778.68},{"date":"2024-03-08","current":-3.286469,"twenty":-5.934258,"median":-4.203753,"eighty":-2.884297,"marketCap":78973557.96},{"date":"2024-03-15","current":-3.777454,"twenty":-5.934258,"median":-4.203753,"eighty":-2.886176,"marketCap":77557312.07},{"date":"2024-03-22","current":-3.777454,"twenty":-5.934258,"median":-4.203753,"eighty":-2.897219,"marketCap":77470194.13},{"date":"2024-03-28","current":-3.750278,"twenty":-5.934258,"median":-4.203753,"eighty":-2.92767,"marketCap":76906034.83},{"date":"2024-04-05","current":-4.239444,"twenty":-5.935279,"median":-4.203753,"eighty":-2.963037,"marketCap":87178827.91},{"date":"2024-04-12","current":-4.320972,"twenty":-5.935279,"median":-4.219237,"eighty":-2.979326,"marketCap":87384857.21},{"date":"2024-04-19","current":-3.886216,"twenty":-5.935279,"median":-4.219237,"eighty":-3.0104,"marketCap":78441122.39},{"date":"2024-04-26","current":-4.049274,"twenty":-5.934258,"median":-4.217188,"eighty":-3.03651,"marketCap":82030668.94},{"date":"2024-05-03","current":-4.321037,"twenty":-5.934258,"median":-4.221363,"eighty":-3.050699,"marketCap":87507976.74},{"date":"2024-05-10","current":-4.518395,"twenty":-5.934258,"median":-4.223931,"eighty":-3.071177,"marketCap":93142123.15},{"date":"2024-05-17","current":-4.14409,"twenty":-5.934258,"median":-4.224724,"eighty":-3.105119,"marketCap":85858499.5},{"date":"2024-05-24","current":-3.899004,"twenty":-5.934258,"median":-4.224724,"eighty":-3.135835,"marketCap":80281888.45},{"date":"2024-05-31","current":-3.952783,"twenty":-5.934258,"median":-4.224724,"eighty":-3.150024,"marketCap":81609628.85},{"date":"2024-06-07","current":-3.872114,"twenty":-5.934258,"median":-4.224724,"eighty":-3.164214,"marketCap":79802779.95},{"date":"2024-06-14","current":-3.787264,"twenty":-5.935279,"median":-4.224724,"eighty":-3.186189,"marketCap":77688532.33},{"date":"2024-06-21","current":-3.679057,"twenty":-5.9363,"median":-4.225153,"eighty":-3.200945,"marketCap":75750893.76},{"date":"2024-06-28","current":-3.733161,"twenty":-5.939363,"median":-4.228411,"eighty":-3.206781,"marketCap":76890693.57},{"date":"2024-07-05","current":-3.841368,"twenty":-5.939363,"median":-4.228411,"eighty":-3.220971,"marketCap":79610000.37},{"date":"2024-07-12","current":-3.787264,"twenty":-5.939363,"median":-4.228411,"eighty":-3.241317,"marketCap":78420749.01},{"date":"2024-07-15","current":-3.895472,"twenty":-5.939363,"median":-4.228411,"eighty":-3.243125,"marketCap":80423435.99},{"date":"2024-08-02","current":-4.003679,"twenty":-5.955072,"median":-4.243225,"eighty":-3.295901,"marketCap":81569712.84},{"date":"2024-08-09","current":-3.708648,"twenty":-5.955072,"median":-4.243225,"eighty":-3.336576,"marketCap":75609931.83},{"date":"2024-08-16","current":-3.708648,"twenty":-5.955072,"median":-4.243225,"eighty":-3.37341,"marketCap":75850522.18},{"date":"2024-08-23","current":-3.557555,"twenty":-5.955072,"median":-4.243225,"eighty":-3.417731,"marketCap":73268302.58},{"date":"2024-08-30","current":-3.516347,"twenty":-5.955072,"median":-4.243225,"eighty":-3.453788,"marketCap":73106260.71},{"date":"2024-09-06","current":-3.653705,"twenty":-5.955072,"median":-4.243225,"eighty":-3.473524,"marketCap":75710341.54},{"date":"2024-09-13","current":-3.59938,"twenty":-5.955072,"median":-4.243225,"eighty":-3.502492,"marketCap":74198954.72},{"date":"2024-09-20","current":-3.544428,"twenty":-5.955072,"median":-4.243225,"eighty":-3.516589,"marketCap":73215330.18},{"date":"2024-09-27","current":-3.352094,"twenty":-5.955072,"median":-4.243225,"eighty":-3.516589,"marketCap":69734313.71},{"date":"2024-10-04","current":-3.491253,"twenty":-5.955072,"median":-4.243225,"eighty":-3.516589,"marketCap":72245271.22},{"date":"2024-10-11","current":-4.673331,"twenty":-5.955072,"median":-4.255991,"eighty":-3.530096,"marketCap":95194969.33},{"date":"2024-10-18","current":-4.865762,"twenty":-5.955072,"median":-4.269139,"eighty":-3.550178,"marketCap":98936415.28},{"date":"2024-10-25","current":-4.757999,"twenty":-5.955072,"median":-4.277343,"eighty":-3.57129,"marketCap":96293906.98},{"date":"2024-10-31","current":-4.537976,"twenty":-5.955072,"median":-4.284993,"eighty":-3.571904,"marketCap":91261030.5},{"date":"2024-11-08","current":-4.125433,"twenty":-5.958798,"median":-4.295523,"eighty":-3.588215,"marketCap":83331146.7},{"date":"2024-11-15","current":-3.931498,"twenty":-5.958798,"median":-4.295523,"eighty":-3.604287,"marketCap":77549284.27},{"date":"2024-11-22","current":-3.819966,"twenty":-5.958798,"median":-4.295523,"eighty":-3.63246,"marketCap":75654869.24},{"date":"2024-11-29","current":-3.847849,"twenty":-5.958798,"median":-4.295523,"eighty":-3.642589,"marketCap":75916092.93},{"date":"2024-12-06","current":-3.443546,"twenty":-5.958798,"median":-4.295523,"eighty":-3.646857,"marketCap":67846425.08},{"date":"2024-12-13","current":-3.345956,"twenty":-5.958798,"median":-4.295523,"eighty":-3.646857,"marketCap":65196392.27},{"date":"2024-12-20","current":-3.652668,"twenty":-5.958798,"median":-4.295523,"eighty":-3.648385,"marketCap":70336790.48},{"date":"2024-12-27","current":-3.931498,"twenty":-5.958798,"median":-4.295523,"eighty":-3.652138,"marketCap":75424904.4},{"date":"2025-01-03","current":-3.680551,"twenty":-5.938342,"median":-4.282697,"eighty":-3.652138,"marketCap":70466762.02},{"date":"2025-01-10","current":-3.624785,"twenty":-5.910509,"median":-4.276331,"eighty":-3.652005,"marketCap":69576425.78},{"date":"2025-01-17","current":-3.373839,"twenty":-5.895065,"median":-4.265612,"eighty":-3.63414,"marketCap":64783888.72},{"date":"2025-01-24","current":-3.262307,"twenty":-5.887263,"median":-4.256571,"eighty":-3.63246,"marketCap":62724188.44},{"date":"2025-01-31","current":-2.955594,"twenty":-5.852218,"median":-4.247129,"eighty":-3.59995,"marketCap":56698475.29},{"date":"2025-02-07","current":-3.178658,"twenty":-5.80043,"median":-4.233918,"eighty":-3.588138,"marketCap":61416621.35},{"date":"2025-02-14","current":-3.067126,"twenty":-5.772252,"median":-4.224724,"eighty":-3.571904,"marketCap":59640179.38},{"date":"2025-02-21","current":-2.927711,"twenty":-5.757563,"median":-4.223931,"eighty":-3.57129,"marketCap":56993811.71},{"date":"2025-02-28","current":-2.788296,"twenty":-5.756926,"median":-4.217188,"eighty":-3.552468,"marketCap":53415358.44},{"date":"2025-03-07","current":-3.01136,"twenty":-5.728039,"median":-4.212268,"eighty":-3.543482,"marketCap":58412816.57},{"date":"2025-03-14","current":-2.48009,"twenty":-5.728039,"median":-4.212268,"eighty":-3.543482,"marketCap":54570064.18},{"date":"2025-03-21","current":-2.452836,"twenty":-5.728039,"median":-4.212268,"eighty":-3.543482,"marketCap":54263331.87},{"date":"2025-03-28","current":-2.452836,"twenty":-5.728039,"median":-4.212268,"eighty":-3.543482,"marketCap":54342568.89},{"date":"2025-04-04","current":-1.935015,"twenty":-5.728039,"median":-4.212268,"eighty":-3.543482,"marketCap":43698246.64},{"date":"2025-04-11","current":-1.907761,"twenty":-5.723126,"median":-4.208011,"eighty":-3.542136,"marketCap":43157157.53},{"date":"2025-04-17","current":-2.130201,"twenty":-5.723126,"median":-4.208011,"eighty":-3.542136,"marketCap":48724466.58}],"updateTime":1745091558993}}}